Haripriya Andanamala to Liver Neoplasms
This is a "connection" page, showing publications Haripriya Andanamala has written about Liver Neoplasms.
Connection Strength
0.214
-
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study. Lancet Digit Health. 2026 Feb; 8(2):100952.
Score: 0.214